Press releases & Media

Press releases

• A3P Biomedical appoints Anders Martin-Löf as new CFO
  May 18, 2022
• A3P Biomedical has successfully completed a Private Placement of SEK 400 million
  May 5, 2022
• Study published in European Urology Open Science confirms that Stockholm3 provides increased precision in prostate cancer diagnosis
  February 28, 2022

More press releases

A3P in media

• Stena Sessan, EQT founder Thomas von Koch and one of Sweden’s leading life science investors invest in A3P Biomedical.
  May 6, 2022
• Finally time for public screening of prostate cancer? (In Swedish)
  November 22, 2021
• Stockholm3, in combination with MRI, make general screening of prostate cancer possible (in Swedish)
  October 6, 2021

More articles